Orbit logo

Outcome Reporting Bias in Trials


ORBIT Team

  Professor Doug Altman 

Doug Altman has been director of the Centre for Statistics in Medicine in Oxford since its inception in 1995. He has published over 400 peer reviewed articles, many aimed at clarifying statistical ideas for medical researchers. He is author of Practical Statistics for Medical Research. His varied research interests include the use and abuse of statistics in medical research, studies of prognosis, regression modelling, systematic reviews and meta-analysis, randomised trials, and studies of medical measurement. Doug is senior statistical editor at the BMJ and co-editor-in-chief of Trials. He is actively involved in developing guidelines for reporting research, including CONSORT, STROBE, and PRISMA, and in 2006 founded the EQUATOR Network which seeks to improve the quality of scientific publications by promoting transparent and accurate reporting of health research.
    Dr Kerry Dwan

Kerry completed her PhD in Outcome Reporting Bias in 2010 at the University of Liverpool.  She continued to conduct research in outcome reporting bias whilst working as a statistician for the Cochrane Cystic Fibrosis and Genetic Disorders Group and the Liverpool Reviews and Implementation Group (LRiG) and as  a trial statistician.  Kerry recently left the University of Liverpool to take up the role as Statistical Editor for the Cochrane Editorial Unit and Cochrane Methods Statistical Group.
    Professor Carrol Gamble 
 

Carrol graduated from the University of Liverpool in 1996 with a BSc in Mathematics and Statistics and obtained her PhD in 2000 in Medical Statistics at Queen Mary and Westfield College, University of London. Carrol became a Lecturer in Medical Statistics at the Liverpool School of Tropical Medicine building on existing interests in meta-analysis and developing interests in clinical trials. In 2002 Carrol moved to the University of Liverpool Biostatistics Department and is now Deputy Director of the Clinical Trials Research Centre with clinical trials experience covering areas such as paediatrics, infection, surgical trials, emergency care, investigational medicinal products and devices. Carrol is co-leader of the later phase trials theme of the MRC funded North West Hub for Trials Methodology Research with research interests including deferred consent, recruitment,  retention and patient and public involvement.

    Dr Jamie Kirkham

Jamie qualified with a PhD in Medical Statistics (2006) at the University of Lancaster.  He has worked in the area of outcome reporting bias as a research associate in the Department of Biostatistics at the University of Liverpool until 2010 and as a Lecturer until 2014.  He is now a Senior Lecturer in Medical Statistics at the University of Liverpool.  His research agenda generally focusses around outcomes based research and he is a co-lead of the Hubs for Trials Methodology Research Outcomes Working Group.  Jamie has a growing publication record in the area of selective reporting, has advised on a number of international committee's in this field and developed numerous training workshops to help raise awareness and to prevent this problem affecting the medical literature.      
    Professor Paula Williamson 

Paula Williamson is Professor of Medical Statistics and Director of the Clinical Trials Research Centre (CTRC) at the University of Liverpool. She is an Associate Director of the NIHR Medicines for Children Research Network, and Director of the MCRN Clinical Trials Unit. In 2008 she led a successful bid to create the MRC North West Hub for Trials Methodology Research (NWHTMR), focussing on three themes (early phase trial design and analysis, later phase trial design and analysis, patients’ perspectives), and developing methods for application across key clinical areas including paediatrics, drug safety, cancer and epilepsy.  Paula is currently the  Network Chair for the Hubs for Trials Methodology Research Network and is a management group member of the Core Outcome Measures in Effectiveness Trials (COMET) Initiative.